In the past decade, the Centre supported a total of 128 companies’ representatives on their road to access the Japanese market. Here are abstracts of 2 success stories by former participants. The whole interviews are available on our website.
Selvita – Poland
Selvita is a polish CRO (Contract Research Organisation) driven by a clear purpose: to bridge the gap between early drug discovery and the clinical stage of drug development by providing state of the art scientific support. Founded in 2007 as a small start-up in Poland, it has rapidly grown over the years to a global organisation, employing over 900 highly motivated specialists at six sites in four countries.
Novaptech – France
Novaptech, a French biotech SME, specializes in the development of aptamer-based tools and devices for applications across health, agri-food, and environmental sectors. Aptamers are artificially synthesized short sequences of DNA, RNA, or XNA designed to bind selectively to a specific target molecule or a family of target molecules.
The EU-Japan Centre currently produces 5 newsletters :
Joint venture established in 1987 by the European Commission (DG GROW) and the Japanese Government (METI) for promoting all forms of industrial, trade and investment cooperation between the EU and Japan.
The EU-Japan Centre’s activities are subject to the allocation of a Grant Agreement by the European Commission for 2024-2026
